
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[AZN] Astrazeneca plc - Shareholder Equity / Assets
Data updated 2023-Sep-23 (Saturday)Note: Detailed Statistics for Shareholder Equity / Assets in Balance Sheet for Astrazeneca plc [NASDAQ:AZN] with frequency distribution chart that analyze trends & history . Total Shareholder Equity / Total Assets is expressed as a %. View Balance Sheet for broader context
Share
Quarterly Shareholder Equity / Assets values for Astrazeneca plc are rounded to enhance readability
2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | |
---|---|---|---|---|---|---|
Shareholder Equity / Assets | 38.7% | 37.0% | 38.4% | 37.3% | 37.2% | 36.2% |
Sequential Quarter Growth | +4.6% | -3.6% | +2.9% | +0.3% | +2.6% | -2.8% |
Quarter-on Quarter Growth | +4.1% | +2.2% | +3.0% | +0.6% | +74.7% | +63.0% |
Annual Shareholder Equity / Assets values for Astrazeneca plc are rounded to enhance readability
2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
---|---|---|---|---|---|---|
Shareholder Equity / Assets | 38.4% | 38.4% | 37.3% | 23.4% | 21.4% | 20.6% |
Year-on-Year Growth | 0.0% | +3.0% | +59.2% | +9.4% | +4.0% | -12.9% |
2-yr CAGR | +1.5% | +28.1% | +32.0% | +6.7% | -4.8% | -18.2% |
3-yr CAGR | +17.9% | +21.5% | +21.9% | -0.3% | -11.4% | -15.0% |
4-yr CAGR | +15.7% | +16.9% | +12.1% | -6.6% | -10.6% | -16.1% |
5-yr CAGR | +13.3% | +10.2% | +3.9% | -6.9% | -12.4% | -14.2% |
Frequency distribution of quarterly Shareholder Equity / Assets values from 2016-Jun-30 grouped into buckets. Latest Shareholder Equity / Assets value is 38.7 as of 2023-Jun-30
Subsequent stock performance post earnings date till next announcement for Astrazeneca plc mapped with quarterly Shareholder Equity / Assets values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Shareholder Equity / Assets above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Astrazeneca plc with subsequent post-earnings performance given Shareholder Equity / Assets values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Shareholder Equity / Assets - Low | 60% | 40% |
Shareholder Equity / Assets - Medium | 44% | 56% |
Shareholder Equity / Assets - High | 44% | 56% |
Shareholder Equity / Assets (Sequential growth %) - Low | 44% | 56% |
Shareholder Equity / Assets (Sequential growth %) - Medium | 56% | 44% |
Shareholder Equity / Assets (Sequential growth %) - High | 44% | 56% |
Shareholder Equity / Assets (QoQ growth %) - Low | 63% | 38% |
Shareholder Equity / Assets (QoQ growth %) - Medium | 38% | 63% |
Shareholder Equity / Assets (QoQ growth %) - High | 50% | 50% |
Related to Astrazeneca plc
Information for Astrazeneca plc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Aug-08 on Google
SEC Reports : Quarterly reports around 2025-Aug-08 on SEC Edgar
Compare Astrazeneca plc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Astrazeneca plc
Industry : Pharmaceuticals industry performance which includes Astrazeneca plc